Screening and Test Evaluation Program (STEP)

筛选和测试评估计划 (STEP)

• 批准号: nhmrc : 402764
• 负责人: Prof Glenn Salkeld
• 金额: $ 447.12万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2006
• 资助国家: 澳大利亚
• 起止时间: 2006-01-01 至 2010-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/screening-test-evaluation-program-step/100414
• 关键词: Screening; Test; Evaluation; Program; STEP

This program, run by an established team with skills in public health, clinical epidemiology, biostatistics, health economics and behavioural science addresses the under-researched issues of whether, when and how to use medical tests. The elements of the program follow the sequence in which testing is often done: for screening (early detection), for diagnosis on which to base treatment decisions, and for monitoring the effects of treatment. A common approach throughout is the identification of the benefits and harms of testing and assessing their trade-off; how benefits weigh up against harms. This research is relevant to all partners in healthcare, (consumers, clinicians and policy-makers), who currently are being tested or using tests without being fully informed about the accuracy and effects of these tests.

该计划由一个拥有公共卫生，临床流行病学，生物统计学，卫生经济学和行为科学技能的成熟团队管理，解决了是否，何时以及如何使用医学测试的研究不足的问题。该计划的要素遵循测试通常进行的顺序：筛查（早期检测），诊断（治疗决策的基础），以及监测治疗效果。贯穿始终的一种常见方法是识别测试的益处和危害，并评估其权衡;如何权衡益处与危害。这项研究与医疗保健领域的所有合作伙伴（消费者、临床医生和政策制定者）相关，他们目前正在接受测试或使用测试，但没有充分了解这些测试的准确性和效果。